Phase I trial of MSC2490484A in combination with radiotherapy (#677)
Laufzeit: 01.01.2017 - 31.12.2020
Kurzfassung
An open label, phase Ia/Ib trial of the DANN-PK inhibitor MSC2490484A in combination with radiotherapy in patients with advanced solid tumors
